Cancer control in India - Role of cancer registries

Do all hormone sensitive prostate cancers need triplet therapy?

Panel Discussion: Case based discussions muscle invasive bladder cancer

I-DXd shows strong brain metastasis responses in extensive-stage small cell lung cancer with manageable safety

Tarlatamab for SCLC: Subgroup analysis shows benefit regardless of previous chemo or anti-PD-(L)1 use

Choosing Wisely for genitourinary cancers

Tarlatamab improves survival over chemo in 2L SCLC regardless of prior immunotherapy or chemo

Temab-A plus bevacizumab shows promising response rates in advanced colorectal cancer

ESMO 2025: Latest developments in endometrial cancer

ESMO 2025: Highlights and analysis

PRAME-targeted TCR therapy shows high response rates in metastatic uveal melanoma

Best practice in precision medicine for prostate cancer